OptimizeRx (OPRX) Operating Expenses (2010 - 2026)

OptimizeRx has disclosed Operating Expenses across 17 years of filings, most recently posting $20.6 million for Q2 2026.

• In Q2 2026, Operating Expenses fell 20.76% year-over-year to $20.6 million; the TTM figure through Jun 2026 stood at $71.0 million (down 21.43% YoY), while the FY2025 annual figure was $61.9 million, down 15.3% from the prior year.
• Operating Expenses came in at $20.6 million for Q2 2026 at OptimizeRx, up from $19.4 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $28.7 million in Q4 2023 to a low of $11.9 million in Q1 2022.
• Average Operating Expenses over 5 years is $17.5 million, with a median of $15.5 million recorded in 2025.
• Year-over-year, Operating Expenses jumped 115.82% in 2023 and sank 36.03% in 2024.
• Over 5 years, Operating Expenses stood at $13.3 million in 2022, then surged by 115.82% to $28.7 million in 2023, then slumped by 36.03% to $18.4 million in 2024, then slipped by 15.54% to $15.5 million in 2025, then jumped by 32.59% to $20.6 million in 2026.
• Per Business Quant data, the three most recent Operating Expenses figures were $20.6 million in Q2 2026, $19.4 million in Q1 2026, and $15.5 million in Q4 2025.